JAK Inhibitors in the Management of Atopic Dermatitis

home / frontline-forum / jak-inhibitors-in-the-management-of-atopic-dermatitis

JAK Inhibitors in the Management of Atopic Dermatitis

Experts in dermatology discuss practical and clinical considerations in the utilization of JAK inhibitors in the management of patients suffering from atopic dermatitis.

Videos
Optimizing Patient Outcomes with JAK Inhibitors

Optimizing Patient Outcomes with JAK Inhibitors

January 19th 2023

Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.

Efficacy and Safety of JAK inhibitors for AD

Efficacy and Safety of JAK inhibitors for AD

January 19th 2023

Experts in atopic disease management review the efficacy and safety data of the JAK inhibitor class, highlighting the importance of time to treatment response and itch reduction.

View More >>
© 2023 MJH Life Sciences

All rights reserved.